JILLIAN CAROLLA: Open Payments
NPI 1487354890 · WILLIAMSPORT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 40 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $287 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $147 |
| Alkermes, Inc. | 8 | $125 |
| Otsuka America Pharmaceutical, Inc. | 5 | $103 |
| Teva Pharmaceuticals USA, Inc. | 4 | $63 |
| ABBVIE INC. | 4 | $60 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Lundbeck LLC | 2 | $33 |
| Neurocrine BioSciences, Inc. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
Products named: CAPLYTA, LYBALVI, REXULTI, VRAYLAR, ABILIFY MAINTENA, UZEDY, COBENFY, INGREZZA.
Industry payments across PA — which companies pay providers there.
